Clinical trial
Effects of Once Daily Tiotropium in Patients With Chronic Obstructive Pulmonary…
NCT00274573 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00274573 |
|---|---|
| Title | Effects of Once Daily Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) of Different Severity |
| Official title | Acute and Long-term Effects of Once Daily Oral Inhalation of Tiotropium 18 Mcg Dry Powder Inhalation Capsules in a Placebo Controlled Parallel Group Design Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) of Different Severity |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | Tiotropium bromide |
| Enrollment | 1,639 |
| Start date | Mar 1, 2002 |
| Primary completion | Oct 1, 2002 |
| First posted | Jan 11, 2006 |
| Last update posted | Nov 21, 2013 |
| Countries | Germany |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: